货号:GS40335
Indatuximab is an investigational antibody-drug conjugate (ADC) developed for the treatment of multiple myeloma and potentially other CD138-positive malignancies. It is engineered by linking a monoclonal antibody to a potent cytotoxic drug via a specialized chemical linker. The antibody component of indatuximab is designed to specifically target CD138 (syndecan-1), a proteoglycan highly expressed on the surface of malignant plasma cells.
武汉迈思生物科技有限公司
联系商家时请提及chemicalbook,有助于交易顺利完成!
迈思生物